Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30 + lymphoproliferative disorder: A case report.
Giulia CeglieRita De VitoMatilde CossuttaAlice TiberiRoberto CartaEmilia BoccieriGiuseppe PalumboPublished in: Pediatric blood & cancer (2022)